March 6, 2020

  • Dr. Tabak presents plaque to Dr. Barabino

    Barabino Sorts Out Mechanics of Sickle Cell Disease

    Sickle cell disease is a painful condition caused by a single amino acid that has gone awry and typically results in 30 years less life expectancy for those who have it. Dr. Gilda Barabino of the City College of New York is leveraging what we know about cell and tissue biomechanics to treat and track SCD.
  • Potential Treatment Found for Alcoholic Liver Disease

    An anti-inflammatory called hyaluronic acid 35 (HA 35) might one day protect patients from the complications of moderate alcoholic liver disease, said Dr. Laura Nagy at NIAAA’s 24th annual Mark Keller Honorary Lecture. “We’re in the planning stage for conducting a pilot clinical trial, to see whether providing HA 35 to healthy adults before a single alcoholic drink can protect the gut,” she said.
  • Shanechi extends her hands as she explains her work, in Neuroscience Center conference room.

    Shanechi Explores How to Decode Mood

    Is it possible to predict our mental state? Dr. Maryam Shanechi is pioneering work to model and decode mood variations, efforts that ultimately could enable modulating brain networks to help patients with treatment-resistant depression and other neuropsychiatric disorders.
  • Dr. James P. Allison

    WALS Talks Feature Nobel Laureate Allison, Dyer Lecturer Cooper

    The NIH Director’s Wednesday Afternoon Lecture Series will host a lecture by recent Nobel laureate Dr. James P. Allison on Mar. 11 and on Mar. 18, the Dyer Lecture by Dr. Lisa A. Cooper, Bloomberg distinguished professor, health and health care equity.
A research participant is prepared for fNIRS.

On the Cover

Near-infrared spectroscopy (fNIRS). A research participant is prepared for fNIRS, which assesses brain activation during motion capture, at the NIH Motion Analysis Lab.

Photo: NIH